Tiger Pharmaceuticals (03347) had a net loss of 272 million yuan in the first three quarters, a year-on-year profit to loss

Zhitongcaijing · 4d ago

According to the Zhitong Finance App, Tiger Pharmaceuticals (03347) announced the results for the first three quarters of 2026. The group achieved operating income of 5.792 billion yuan in the first three quarters, an increase of 15.23% over the previous year; a net loss of 272 million yuan to the mother, a year-on-year profit and loss; and a basic loss of 0.32 yuan per share.